ILITE
LIVE

Serial Number

79243106

Owner

SVAR Life Science AB

Attorney

GREGORY J. CHINLUND

Filing Date

Jun 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ILITE Trademark

Serial Number: 79243106 • Registration: 6077015

ILITE is a trademark filed by SVAR Life Science AB on June 5, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SVAR Life Science AB (5 trademarks)

Box 50117

Entity Type: 09

Trademark Details

Filing Date

June 5, 2018

Registration Date

June 16, 2020

Published for Opposition

March 31, 2020

Goods & Services

Laboratory apparatus in the nature of instruments for use in performing cell-based assays by means of optic detection, namely, optical quantification apparatus; computer software for use in optic based biological analysis; computer software for use in optic based biological analysis such as tools and methods used during drug development, clinical diagnosis, clinical monitoring or assay development

Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use

Substances for use in cell-based reporter gene assays, namely, assays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposes, namely, reagents for scientific and research use; reagents for chemical analyses, namely, chemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research use, namely, cell lines; components for cell-based analyses using optical methods and containing chemical reagents, namely, cells for scientific and research use

Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes; medical services, namely, treating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services

Medical diagnostic apparatus for use in testing assays

Cell-based assay services, namely, custom design and development of cell-based biochemical assays; cell-based assay services, namely, custom design and development of cell-based biochemical assays for use in drug development, clinical diagnosis, clinical monitoring or assay development; medical research; clinical research in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; conducting clinical trials for others; scientific, medical laboratory research and analysis services; scientific and medical laboratory testing services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 16, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 3, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 16, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 15, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 29, 2020 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 27, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 11, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 11, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2020 CNSA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 13, 2020 ADCH
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 10, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 10, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 10, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2019 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2019 RFNT
NON-FINAL ACTION MAILED
Jun 26, 2019 CNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2019 CRFA
ASSIGNED TO LIE
Jun 4, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2019 RFNT
NON-FINAL ACTION MAILED
Jan 18, 2019 CNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2019 CNRT
REFUSAL PROCESSED BY IB
Dec 21, 2018 RFNT
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Dec 13, 2018 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 30, 2018 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2018 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 23, 2018 MAFR
ASSIGNED TO EXAMINER
Oct 19, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 18, 2018 REPR